Xunyi Luo

发表

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

B. Faubert, Russell G. Jones, S. Berger, 2011, Genes & development.

Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.

Narendra Kumar Patel, T. Mak, N. Chirgadze, 2014, Bioorganic & medicinal chemistry.

Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-κB Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-α During T Cell Activation1 2

Yufang Shi, Xunyi Luo, J. Moreno, 2001, The Journal of Immunology.

a relevant functional ion channel in platelets ? variant lacking 17 amino acids in its extracellular domain 2 X 1 delDoes the P

J. Vermylen, M. Hoylaerts, C. Oury, 2002 .

The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents.

Y. Liu, T. Mak, P. Sampson, 2013, Journal of medicinal chemistry.

The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.

Narendra Kumar Patel, Y. Liu, T. Mak, 2015, Journal of medicinal chemistry.

Identification and characterization of survival-related gene, a novel cell survival gene controlling apoptosis and tumorigenesis.

Hong Sun, Yufang Shi, Xunyi Luo, 2005, Cancer research.

Suppression of EGFRvIII‐mediated proliferation and tumorigenesis of breast cancer cells by ribozyme

Careen K. Tang, Xunyi Luo, X. Gong, 2003, International journal of cancer.

Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure.

G. Tonon, Yufang Shi, Xunyi Luo, 2002, Thrombosis research.

Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways

Baljit Singh, Careen K. Tang, Hong Yu, 2008, Cancer biology & therapy.

Design and optimization of (3-aryl-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-ones as potent PLK4 inhibitors with oral antitumor efficacy.

Narendra Kumar Patel, T. Mak, P. Sampson, 2016, Bioorganic & medicinal chemistry letters.

γ-Synuclein Is an Adipocyte-Neuron Gene Coordinately Expressed with Leptin and Increased in Human Obesity

K. Clément, V. Buchman, S. Adams, 2008, The Journal of nutrition.

Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia

G. Tonon, Xunyi Luo, N. Greco, 2017 .

represent a relevant functional ion channel in platelets? variant lacking 17 amino acids in its extracellular domain 2X1del Does the P

G. Tonon, J. Vermylen, M. Hoylaerts, 2009 .

adenosine diphosphate in platelets and megakaryocytic cells Novel structurally altered P2X1 receptor is preferentially activated by

G. Tonon, Xunyi Luo, N. Greco, 2013 .

During T Cell Activation a TNF-Apoptosis-Inducing Ligand (TRAIL), and B Ligand (RANKL), TNF-Related k Factor-CD95 Ligand, Receptor Activator of Nuclear Differential Regulation of the Expression of

Yufang Shi, Xunyi Luo, J. Moreno, 2001 .

The discovery of Polo-like kinase 4 inhibitors: identification of (1R,2S).2-(3-((E).4-(((cis).2,6-dimethylmorpholino)methyl)styryl). 1H.indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a potent, orally active antitumor agent.

Narendra Kumar Patel, Y. Liu, T. Mak, 2015, Journal of medicinal chemistry.